Advertisement
CTOR vs UPC
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTOR is a Hold and UPC is a Hold.
CTOR's RSI Indicator sits in oversold zone for 4 days
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 15 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
CTOR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CTOR as a result. In 42 of 58 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 72%.
The Moving Average Convergence Divergence Histogram (MACD) for CTOR turned negative on September 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 34 similar instances when the indicator turned negative. In 15 of the 34 cases the stock turned lower in the days that followed. This puts the odds of success at 44%.
CTOR moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CTOR crossed bearishly below the 50-day moving average on October 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 7 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTOR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
The Aroon Indicator for CTOR entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 36 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.518) is normal, around the industry mean (9.012). P/E Ratio (-1.207) is within average values for comparable stocks, (-3.044). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.037) among similar stocks. P/S Ratio (12.547) is also within normal values, averaging (178.797).
The Tickeron PE Growth Rating for this company is 42 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. CTOR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CTOR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
UPC's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for UPC turned positive on October 22, 2026. Looking at past instances where UPC's MACD turned positive, the stock continued to rise in 41 of 44 cases over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where UPC's RSI Oscillator exited the oversold zone, 35 of 39 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on UPC as a result. In 80 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 89%.
Following a +24.86% 3-day Advance, the price is estimated to grow further. Considering data from situations where UPC advanced for three days, in 179 of 214 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
UPC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
UPC moved below its 50-day moving average on September 21, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UPC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for UPC entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 34 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.808) is normal, around the industry mean (9.012). P/E Ratio (-0.001) is within average values for comparable stocks, (-3.044). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.037) among similar stocks. P/S Ratio (0.150) is also within normal values, averaging (178.797).
The Tickeron PE Growth Rating for this company is 41 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. UPC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UPC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
| CTOR | UPC | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 90% | 4 days ago 90% |
| Stochastic ODDS (%) | 4 days ago 73% | 4 days ago 90% |
| Momentum ODDS (%) | 4 days ago 72% | 4 days ago 89% |
| MACD ODDS (%) | 4 days ago 44% | 4 days ago 90% |
| TrendWeek ODDS (%) | 4 days ago 75% | 4 days ago 87% |
| TrendMonth ODDS (%) | 4 days ago 90% | 4 days ago 90% |
| Advances ODDS (%) | N/A | 5 days ago 84% |
| Declines ODDS (%) | 4 days ago 87% | 7 days ago 90% |
| BollingerBands ODDS (%) | 4 days ago 85% | 4 days ago 90% |
| Aroon ODDS (%) | 4 days ago 89% | 4 days ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CTOR’s FA Score shows that 0 FA rating(s) are green while UPC’s FA Score has 0 green FA rating(s).
- CTOR’s FA Score: 0 green, 5 red.
- UPC’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CTOR’s TA Score shows that 3 TA indicator(s) are bullish while UPC’s TA Score has 5 bullish TA indicator(s).
- CTOR’s TA Score: 3 bullish, 6 bearish.
- UPC’s TA Score: 5 bullish, 4 bearish.
Price Growth
CTOR (@Pharmaceuticals: Generic) experienced а -24.53% price change this week, while UPC (@Pharmaceuticals: Generic) price change was +9.41% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +46.28%. For the same industry, the average monthly price growth was -6.72%, and the average quarterly price growth was +8.01%.
Reported Earning Dates
CTOR is expected to report earnings on Dec 17, 2026.
Industries' Descriptions
@Pharmaceuticals: Generic (+46.28% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
Advertisement
CTOR and
Correlation & Price change
A.I.dvisor tells us that CTOR and BFRI have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CTOR and BFRI's prices will move in lockstep.
| Ticker / NAME | Correlation To CTOR | 1D Price Change % | ||
|---|---|---|---|---|
| CTOR | 100% | -17.16% | ||
| BFRI - CTOR | 26% Poorly correlated | +1.04% | ||
| PRGO - CTOR | 26% Poorly correlated | -2.50% | ||
| IMCC - CTOR | 23% Poorly correlated | -5.08% | ||
| RDHL - CTOR | 21% Poorly correlated | +0.26% | ||
| HIMS - CTOR | 21% Poorly correlated | -4.87% | ||
More | ||||
UPC and
Correlation & Price change
A.I.dvisor indicates that over the last year, UPC has been loosely correlated with BIOA. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if UPC jumps, then BIOA could also see price increases.
| Ticker / NAME | Correlation To UPC | 1D Price Change % | ||
|---|---|---|---|---|
| UPC | 100% | -2.71% | ||
| BIOA - UPC | 50% Loosely correlated | -7.78% | ||
| HCM - UPC | 22% Poorly correlated | +0.56% | ||
| TXMD - UPC | 22% Poorly correlated | -2.70% | ||
| CRON - UPC | 13% Poorly correlated | -2.76% | ||
| CTOR - UPC | 13% Poorly correlated | -17.16% | ||
More | ||||